Long-Time NIH Grantee Wins Nobel Prize In Chemistry

October 15, 1997

Dr. Paul D. Boyer, a long-time NIH grantee, is one of three recipients of the 1997 Nobel Prize in chemistry. Boyer, who is a professor emeritus of biochemistry at the University of California, Los Angeles, received over $4.4 million in research grant support from NIH between 1948 and 1996. The vast majority of this support was from the National Institute of General Medical Sciences, with other funding coming from the National Institute of Diabetes and Digestive and Kidney Diseases.

Dr. Jens C. Skou of Aarhus University in Denmark, one of the other prize recipients, received support from NIH's National Institute of Neurological Disorders and Stroke in the early 1960's.

"The Nobel Prize recognizes Dr. Boyer for a lifetime spent investigating the molecular mechanism by which ATP--the cellular energy that drives all biological reactions--is formed," said Dr. Marvin Cassman, NIGMS Director. "Determining how ATP is synthesized has been a central problem in biology for decades and is at the core of an understanding of metabolic processes in the cell. Dr. Boyer has been a key contributor to the molecular understanding of ATP synthesis."

Since the early 1950's, Boyer has sought to understand the inner workings of ATP synthase, the enzyme he calls the "splendid molecular machine" that produces ATP. The enzyme is a complex protein rooted in the inner membranes of cellular structures called mitochondria, the "powerhouses of the cell."

Over several decades, Boyer developed a model of how the various subunits of the enzyme work together like gears, levers, and ratchets to generate cellular energy. His theories were confirmed in 1994 with a detailed, three-dimensional structure of the enzyme determined by the third recipient of the chemistry prize, Dr. John E. Walker of the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK. The techniques Boyer developed are now commonly used to study other ATP-utilizing enzymes.

NIGMS funds research and research training in the basic biomedical sciences, including chemistry. It has supported 22 of the 28 Nobel laureates in chemistry funded or employed by NIH since 1954.

Please call the NIGMS Public Information Office at (301) 496-7301 to interview a scientist who can give perspective on Dr. Boyer's research.
-end-


NIH/National Institute of General Medical Sciences

Related Enzyme Articles from Brightsurf:

Repairing the photosynthetic enzyme Rubisco
Researchers at the Max Planck Institute of Biochemistry decipher the molecular mechanism of Rubisco Activase

Oldest enzyme in cellular respiration isolated
Researchers from Goethe University have found what is perhaps the oldest enzyme in cellular respiration.

UQ researchers solve a 50-year-old enzyme mystery
Advanced herbicides and treatments for infection may result from the unravelling of a 50-year-old mystery by University of Queensland researchers.

Overactive enzyme causes hereditary hypertension
After more than 40 years, several teams at the MDC and ECRC have now made a breakthrough discovery with the help of two animal models: they have proven that an altered gene encoding the enzyme PDE3A causes an inherited form of high blood pressure.

Triggered by light, a novel way to switch on an enzyme
In living cells, enzymes drive biochemical metabolic processes. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics.

A 'corset' for the enzyme structure
The structure of enzymes determines how they control vital processes such as digestion or immune response.

Could inhibiting the DPP4 enzyme help treat coronavirus?
Researchers and clinicians are scrambling to find ways to combat COVID-19, including new therapeutics and eventually a vaccine.

Bacterial enzyme could become a new target for antibiotics
Scientists discover the structure of an enzyme, found in the human gut, that breaks down a component of collagen.

Chemists create new artificial enzyme
Rajeev Prabhakar, a computational chemist at the University of Miami, and his collaborators at the University of Michigan have created a novel, synthetic, three-stranded molecule that functions just like a natural metalloenzyme, or an enzyme that contains metal ions.

First artificial enzyme created with two non-biological groups
Scientists at the University of Groningen turned a non-enzymatic protein into a new, artificial enzyme by adding two abiological catalytic components: an unnatural amino acid and a catalytic copper complex.

Read More: Enzyme News and Enzyme Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.